Top Markets
Coin of the day
Cell MedX Corp. Cell MedX Corp.

Cell MedX Corp.

CMXC
株式のランク #30404
Cell MedX Corp. is a biotechnology firm dedicated to identifying, developing,... Cell MedX Corp. is a biotechnology firm dedicated to identifying, developing, and marketing both therapeutic and non-therapeutic solutions aimed at individuals suffering from conditions such as diabetes, Parkinson's disease, hypertension, neuropathy, and various kidney-related ailments. The company's offerings include the eBalance Pro System, designed for clinical application by medical professionals, and the eBalance Home System, intended for personal use to promote general well-being and alleviate pain. Both systems are managed by the eBalance Console, a central control unit featuring three distinct pre-programmed microcurrent algorithms: wellness, pain management, and a dual mode. Originally established in 2010 as Sports Asylum, Inc., the company adopted its current name, Cell MedX Corp., in September 2014. Its operations are headquartered in Carson City, Nevada.
株価
$0.41
最終同期: 2024-12-24
時価総額
$16.96M
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Cell MedX Corp. (CMXC)

カテゴリー

Cell MedX Corp.(CMXC)の配当利回りの履歴
Cell MedX Corp.(銘柄コード: CMXC)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Cell MedX Corp.(CMXC)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)